Skip to Content

Orphenadrine Citrate Injection

Last Updated: February 16, 2017
Status: Resolved

Products Affected - Description

All presentations are currently available

Reason for the Shortage

  • Akorn had orphenadrine citrate injection on shortage due to manufacturing delays.
  • Actavis did not provide a reason for the orphenadrine citrate shortage.
  • Sagent is no longer marketing orphenadrine citrate.

Available Products

Orphenadrine Citrate solution for injection, Actavis
30 mg/mL, 2 mL vial, 10 count (NDC 00591-3222-47)

Orphenadrine Citrate solution for injection, Akorn
30 mg/mL, 2 mL vial, 10 count (NDC 17478-0538-02)

Estimated Resupply Dates

All marketed presentations are available.

Related Shortages

Updated

February 16, January 19, 2017; November 29 and 21, October 17, 2016, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide